Implantation of Left Ventricular Epicardial Leads in Cardiosurgical Patients with Impaired Cardiac Function–A Worthwhile Procedure in Concomitant Surgical Interventions?^[*]

Abstract

Background Cardiac resynchronization therapy (CRT) by means of multisite biventricular pacing is an effective therapeutic option for the treatment of severe heart failure. The present study estimates how many open heart-surgery patients could benefit from the implantation of permanent left ventricular (LV) pacing leads. After routine preoperative screening, epicardial electrodes were implanted in selected patients. Lead performance and outcomes were investigated.

Methods Primarily, 1059 patients were retrospectively investigated with regard to LV function, left bundle branch block and QRS duration. Afterwards, suitable patients were identified and epicardial electrodes [Medtronic 5071 (ME) or Enpath (EP)] were implanted during concomitant procedures. Mean follow-up time was 6.3 ± 5.5 months.

Results The retrospective study showed that 24 patients (2.3%) could potentially profit from CRT. After routine preoperative screening for CRT-responders, 22 patients (1.6%) were identified who finally received epicardial leads. No complications occurred. Acute capture threshold was 0.9 ± 0.4 V (ME, n = 17) and 0.5 ± 0.2 V (EP, n = 5). While leads in 18 patients were implanted as an upgrade to an existing pacemaker or implantable cardioverter-defibrillator (ICD) technologies (Group B), 4 patients underwent prophylactic implantation with no device attached (Group A). CRT-ICDs were implanted at follow-up in 3 Group A patients (75%). In Group B patients, the QRS duration decreased (from 189 ± 35 ms to 152 ± 16 ms, p < 0.02) and their postoperative mean NYHA functional class improved significantly (2.2 ± 0.5 versus 2.8 ± 0.6).

Conclusion A small group of cardiac surgery patients may benefit from LV-lead implantation during concomitant procedures. A protocol for responder identification is useful. Existing devices should be upgraded to CRT systems. As CRT-ICD implantation is frequent, the additional costs and time are justified.

Keywords

pacing (incl. resynchronization/biventricular) - heart failure - cardiac

• References

• 1 Swedberg K, Cleland J, Dargie H , et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005; 26: 1115-1140
• 2 Hunt SA, Abraham WT, Chin MH , et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005; 112: e154-e235
• 3 Dickstein K, Cohen-Solal A, Filippatos G , et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008; 29: 2388-2442
• 4 Hoppe UC, Boehm M, Drexler H , et al. Kommentar zu den ESC-Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008. Der Kardiologe 2009; 3: 16-23
• 5 Mair H, Sachweh J, Meuris B , et al. Surgical epicardial left ventricular lead versus coronary sinus lead placement in biventricular pacing. Eur J Cardiothorac Surg 2005; 27: 235-242
• 6 Duray GZ, Israel CW, Pajitnev D, Hohnloser SH. Upgrading to biventricular pacing/defibrillation systems in right ventricular paced congestive heart failure patients: prospective assessment of procedural parameters and response rate. Europace 2008; 10: 48-52
• 7 Henglein D, Gillette PC, Shannon C, Burns G. Long-term follow-up of pulse width threshold of transvenous and myo-epicardial leads. Pacing Clin Electrophysiol 1984; 7: 203-214
• 8 Beder SD, Kuehl KS, Hopkins RA, Tonder LM, Mans DR. Precipitous exit block with epicardial steroid-eluting leads. Pacing Clin Electrophysiol 1997; 20: 2954-2957
• 9 Sachweh JS, Vazquez-Jimenez JF, Schondube FA , et al. Twenty years experience with pediatric pacing: epicardial and transvenous stimulation. Eur J Cardiothorac Surg 2000; 17: 455-461
• 10 Aellig NC, Balmer C, Dodge-Khatami A, Rahn M, Pretre R, Bauersfeld U. Long-term follow-up after pacemaker implantation in neonates and infants. Ann Thorac Surg 2007; 83: 1420-1423
• 11 Murayama H, Maeda M, Sakurai H, Usui A, Ueda Y. Predictors affecting durability of epicardial pacemaker leads in pediatric patients. J Thorac Cardiovasc Surg 2008; 135: 361-366
• 12 Alonso C, Leclercq C, d'Allonnes FR , et al. Six year experience of transvenous left ventricular lead implantation for permanent biventricular pacing in patients with advanced heart failure: technical aspects. Heart 2001; 86: 405-410
• 13 Khan FZ, Virdee MS, Fynn SP, Dutka DP. Left ventricular lead placement in cardiac resynchronization therapy: where and how?. Europace 2009; 11: 554-561
• 14 Giudici MC, Thornburg GA, Buck DL , et al. Comparison of right ventricular outflow tract and apical lead permanent pacing on cardiac output. Am J Cardiol 1997; 79: 209-212
• 15 Leon AR, Greenberg JM, Kanuru N , et al. Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: effect of upgrading to biventricular pacing after chronic right ventricular pacing. J Am Coll Cardiol 2002; 39: 1258-1263
• 16 Baker CM, Christopher TJ, Smith PF, Langberg JJ, Delurgio DB, Leon AR. Addition of a left ventricular lead to conventional pacing systems in patients with congestive heart failure: feasibility, safety, and early results in 60 consecutive patients. Pacing Clin Electrophysiol 2002; 25: 1166-1171
• 17 Witte KK, Pipes RR, Nanthakumar K, Parker JD. Biventricular pacemaker upgrade in previously paced heart failure patients–improvements in ventricular dyssynchrony. J Card Fail 2006; 12: 199-204
• 18 Eldadah ZA, Rosen B, Hay I , et al. The benefit of upgrading chronically right ventricle-paced heart failure patients to resynchronization therapy demonstrated by strain rate imaging. Heart Rhythm 2006; 3: 435-442
• 19 Tesler UF, Lanzillo G, Novelli E, Cerin G, Diena M. Cardiac resynchronization therapy as an adjunct to conventional surgical treatment for heart failure. Tex Heart Inst J 2008; 35: 289-295
• 20 Udink ten Cate F, Breur J, Boramanand N , et al. Endocardial and epicardial steroid lead pacing in the neonatal and paediatric age group. Heart 2002; 88: 392-396
• 21 Silvetti MS, Drago F, De Santis A , et al. Single-centre experience on endocardial and epicardial pacemaker system function in neonates and infants. Europace 2007; 9: 426-431
• 22 Lau EW. Achieving permanent left ventricular pacing-options and choice. Pacing Clin Electrophysiol 2009; 32: 1466-1477
• 23 Papadopoulos N, Rouhollapour A, Kleine P, Moritz A, Bakhtiary F. Long-term follow-up after steroid-eluting epicardial pacemaker implantation in young children: a single centre experience. Europace 2010; 12: 540-543
• 24 Doll N, Piorkowski C, Czesla M , et al. Epicardial versus transvenous left ventricular lead placement in patients receiving cardiac resynchronization therapy: results from a randomized prospective study. Thorac Cardiovasc Surg 2008; 56: 256-261
• 25 Tomaske M, Gerritse B, Kretzers L , et al. A 12-year experience of bipolar steroid-eluting epicardial pacing leads in children. Ann Thorac Surg 2008; 85: 1704-1711